Occudo Quantitative Strategies LP Cti Biopharma Corp Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.36 - $7.43 $742,027 - $1.03 Million	-138,438 Reduced 66.89%	68,516 $399,000
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $443,796 - $783,831	125,013 Added 152.56%	206,954 $1.24 Million
Q1 2022 May 16, 2022	BUY	$1.9 - $5.23 $155,687 - $428,551	81,941 New	81,941 $383,000
Q3 2021 Nov 15, 2021	SELL	$2.25 - $3.18 $124,998 - $176,664	-55,555 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.16 - $2.62 $10,784 - $13,081	-4,993 Reduced 8.25%	55,555 $139,000
Q1 2021 May 14, 2021	BUY	$2.68 - $3.8 $133,104 - $188,730	49,666 Added 456.41%	60,548 $176,000
Q4 2020 Feb 16, 2021	BUY	$2.48 - $3.8 $26,987 - $41,351	10,882 New	10,882 $35,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.